Jin Lim has extensive experience in process chemistry and scientific research, having held various prominent roles in the biotechnology and pharmaceutical industries. Jin Lim began a career as a scientist at SK Chemicals and later transitioned to venture capitalism in biotech with companies such as CCI Investment Inc. and IMM Investment Corp. Following this, Jin Lim served as a research scientist at CTRI Deutschland GmbH and held significant positions, including Senior Scientist at Idenix Pharmaceuticals during its acquisition by Merck & Co. Jin Lim's academic background includes a Postdoc at Yale University in RNA Biology and a PhD in Organic Chemistry from the Korea Advanced Institute of Science and Technology. Currently, Jin Lim is a Senior Advisor at Eli Lilly and has previously contributed to Moderna as a Fellow in Technical Development and a Senior Scientist. During a brief tenure at Verve Therapeutics as an Associate Director, Jin Lim showcased expertise in late-stage process chemistry.
This person is not in the org chart
This person is not in any teams
This person is not in any offices